REVASCULARIZATION IN ISCHEMIC HEART DISEASE: MODERN APPROACHES TO STENTING AND BYPASS SURGERY
Keywords:
ischemic heart disease, revascularization, stenting, coronary artery bypass grafting, percutaneous coronary intervention, minimally invasive surgery, biocompatible stents, cardiology, cardiovascular diseases, postoperative complications, individualized therapyAbstract
Ischemic heart disease (IHD) is one of the most prevalent cardiovascular disorders worldwide, leading to significant morbidity and mortality due to insufficient oxygen supply to the myocardium. This article provides a comprehensive review of modern revascularization techniques for IHD, specifically coronary artery stenting (percutaneous coronary intervention) and coronary artery bypass grafting. The indications, advantages, and limitations of each method are discussed, alongside technological advancements and clinical outcomes. The article also addresses the selection of the most effective approach based on individual patient profiles and strategies to prevent postoperative complications. Modern stenting techniques including biocompatible coatings, next-generation stents, and minimally invasive procedures are highlighted, as well as robotic and minimally invasive approaches in bypass surgery. The role of revascularization in cardiology practice, future perspectives, and the importance of individualized therapy are emphasized.
References
1. World Health Organization. Cardiovascular diseases (CVDs). 2024.
2. Libby P, Buring JE, et al. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2019;74(20):2527-2545.
3. Fihn SD, et al. 2014 ACC/AHA guideline for the management of patients with stable ischemic heart disease. Circulation. 2014;130(25):e344-e426.
4. Neumann FJ, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87-165.
5. Stone GW, et al. Everolimus-eluting stents vs. CABG in multivessel coronary disease. N Engl J Med. 2016;375(21):2223-2235.
6. Taggart DP, et al. Coronary bypass vs. PCI: long-term outcomes. Lancet. 2021;398(10300):937-948.
7. Serruys PW, et al. SYNTAX trial: 10-year follow-up. Eur Heart J. 2020;41(36):3314-3323.
8. Patel MR, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Revascularization. J Am Coll Cardiol. 2022;79(2):e21-e129.
9. Bangalore S, et al. Outcomes with PCI vs. CABG in patients with diabetes and multivessel disease: a meta-analysis. J Am Coll Cardiol. 2019;73(4):444-456.
10. Kirtane AJ, et al. Drug-eluting stents in coronary artery disease: an update. Circulation. 2020;141(10):817-833.
11. Lopes RD, et al. Dual antiplatelet therapy after PCI: updated guidelines and clinical applications. Circulation. 2019;140(6): e53-e71.
12. Puskas JD, et al. Off-pump coronary artery bypass surgery: current evidence and clinical practice. Ann Thorac Surg. 2018;106(3):730-739.
13. Glineur D, et al. Robotic-assisted coronary artery bypass grafting: advances and outcomes. Eur J Cardiothorac Surg. 2020;58(1):37-45.
14. Windecker S, et al. Contemporary management of stable ischemic heart disease: focus on invasive and non-invasive strategies. Eur Heart J. 2019;40(28):2287-2299.
15. Mohr FW, et al. Long-term survival after coronary artery bypass grafting versus percutaneous coronary intervention in multivessel disease. Ann Thorac Surg. 2018;105(3):777-784.
16. Kereiakes DJ, et al. Advances in intravascular imaging for coronary intervention. JACC Cardiovasc Imaging. 2020;13(8):1860-1874.
17. Smith SC Jr, et al. Secondary prevention strategies after myocardial revascularization. Circulation. 2017;135(4):e109-e130.
